Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-100064
Filing Date
2025-07-30
Accepted
2025-07-30 13:33:06
Documents
120
Period of Report
2025-05-31

Document Format Files

Seq Description Document Type Size
1 10-K neog-20250531.htm   iXBRL 10-K 4067523
2 EX-4.3 neog-ex4_3.htm EX-4.3 17517
3 EX-10.16 neog-ex10_16.htm EX-10.16 40528
4 EX-10.17 neog-ex10_17.htm EX-10.17 27710
5 EX-10.19 neog-ex10_19.htm EX-10.19 26474
6 EX-19 neog-ex19.htm EX-19 57909
7 EX-21 neog-ex21.htm EX-21 46890
8 EX-23 neog-ex23.htm EX-23 4195
9 EX-24 neog-ex24.htm EX-24 53546
10 EX-31.1 neog-ex31_1.htm EX-31.1 15978
11 EX-31.2 neog-ex31_2.htm EX-31.2 16235
12 EX-32 neog-ex32.htm EX-32 11451
13 EX-97 neog-ex97.htm EX-97 24725
14 GRAPHIC img194657762_0.jpg GRAPHIC 646845
  Complete submission text file 0000950170-25-100064.txt   20899302

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250531.xsd EX-101.SCH 2638152
123 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250531_htm.xml XML 4269096
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 251165892
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)